This phase I trial tests the safety, side effects, and best dose of Q702 in treating patients with hematologic malignancies. Q702 is in a class of medications …

Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more

~Estimated

~$10 – $6,250

Mayo ClinicNCT06712810

Phase 2

Phase II Study of Salvage Radiation Treatment After B-cell Maturation Antigen Chimeric Antigen Receptor T-cell Therapy for Relapsed Refractory Multiple Myeloma

This study is a Phase II study to determine the preliminary safety and efficacy of salvage radiation treatment after BCMA CAR-T therapy in subjects with RRMM. …

Multiple MyelomaPlasma Cell NeoplasmMalignant Plasma Cell Neoplasm

~Estimated

~$10 – $6,250

M.D. Anderson Cancer CenterNCT05336383

Tissue Procurement For Hematolymphoid Conditions

RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in…

Chronic Myeloproliferative DisordersLeukemiaLymphoma+5 more

~Estimated

~$10 – $750

UNC Lineberger Comprehensive Cancer CenterNCT01137643

← PreviousPage 7 of 7Next →